- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01801267
Third Ventriculostomy Versus Shunt for Children With Hydrocephalus
A Randomized Controlled Trial of Endoscopic Third Ventriculostomy Versus Ventricular Shunt for Children With Communicating Hydrocephalus
Ventriculoperitoneal shunts are the standard of care for patients with communicating hydrocephalus, but they have a high failure rate - up to 40% fail within 1 year and 50% fail within 2 years. It has long been assumed that endoscopic third ventriculostomy (ETV) would not work in this population and is better suited to patients with obstructive hydrocephalus (such as from a tumor blocking cerebral-spinal fluid (CSF) pathways). However, as scientists learn more about CSF and the way our brains absorb this fluid, they have learned that this may not be so straight-forward. Recent small studies have shown that ETVs can work in a good percentage of children with communicating hydrocephalus, too. But no randomized controlled trials have been done to compare these two treatments directly to determine which will provide children with a better prognosis, fewer surgeries over their lifetime, less time in the hospital and the greatest chance at as normal a life as possible.
The investigators will conduct a trial to compare these two surgical treatments where patients will be randomized to receive either a shunt or an ETV. Because ETV has been shown to have a high failure rate in newborns, the investigators will not include these patients and instead will study patients who come to Duke University with communicating hydrocephalus between the ages of 1 year and 18 years. The study will include patients with ventricular shunts who are in need of revision and patients who were just diagnosed and need their first shunt.
All patients who agree to participate will be randomized to receive either an ETV or a shunt. The study team will follow them for one year from the time of the surgery and will determine what percentage of patients require further CSF-related surgeries, how long they go after their surgery before they need another surgery, how much time they spend in the hospital and what percentage of patients suffer CSF-infections or other problems related to the surgery or their hydrocephalus. The study team will examine these results and determine if ETV is a safer or more effective treatment for children with communicating hydrocephalus than is a ventricular shunt.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children age 1-18 years
- Patients with communicating hydrocephalus who present in need of CSF diversion surgery, as diagnosed by radiographic imaging (CT or MRI of brain) as well as clinical signs or symptoms of increased intracranial pressure
- Informed consent according to institutional guidelines must be obtained from each patient's parent or legal guardian, or by the patient him/herself if he/she is 18 years of age
Exclusion Criteria:
- An active Central Nervous System malignancy (cancer)
- The presence of two or more current ventricular catheters indicating that the ventricles do not communicate with each other
- The inability of the parent/guardian or patient to provide informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Endoscopic third ventriculostomy (ETV)
Pediatric patients in need of CSF-diversion surgery will undergo an endoscopic third ventriculostomy (ETV).
|
Pediatric patients in need of CSF-diversion surgery will undergo an endoscopic third ventriculostomy (ETV).
A neurosurgeon will make a small hole in the third ventricle (a fluid space in the brain) to allow CSF to flow out of the ventricles.
Other Names:
|
Active Comparator: Ventricular shunt
Pediatric patients in need of CSF-diversion surgery will undergo ventricular shunt placement or revision.
|
Pediatric patients in need of CSF-diversion surgery will undergo ventricular shunt placement or revision.
A neurosurgeon will insert a small tube into the ventricle (a fluid space in the brain) and connect this tube to another location in the body so that CSF can flow out of the brain and be absorbed elsewhere in the body - the belly, the top of the heart or the side of the lung.
If a patient already has a shunt which is not working, a neurosurgeon will fix or replace it.
This will serve as the Control arm of the study.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time until need for further CSF-related surgeries
Time Frame: one year
|
The measurement will be the time between the initial randomized study surgery and any additional CSF-related surgery that the patient needs for a maximum of one year.
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total number of CSF-related surgeries needed within one year
Time Frame: one year
|
The measurement will be the total number of CSF-related surgeries that a patient requires within one year of their initial randomized study surgery.
|
one year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Morbidities
Time Frame: one year
|
The measurement will be the percentage of patients who suffer CSF-infections or other problems related to the surgery or their hydrocephalus within one year after their initial randomized surgery.
|
one year
|
Time spent in the hospital
Time Frame: one year
|
The measurement will be how much time patients in each group spend in the hospital during the one year after their initial randomized surgery.
|
one year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Carrie R Muh, MD, MS, Duke University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00043098
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Communicating Hydrocephalus
-
CereVasc IncAlvaMed, Inc.; Simplified Clinical Data Systems, LLC; Bioscience Consulting,...RecruitingHydrocephalus | Hydrocephalus, CommunicatingArgentina
-
CereVasc IncAlvaMed, Inc.; Simplified Clinical Data Systems, LLC; Bioscience Consulting,...TerminatedPilot Study to Evaluate the CereVasc® eShunt® System in the Treatment of Communicating HydrocephalusHydrocephalus | Hydrocephalus, CommunicatingUnited States
-
University of ZurichSuspendedShunt; Complications, Ventricular (Communicating)Switzerland
-
University of Kansas Medical CenterNot yet recruitingLow Pressure Hydrocephalus
-
Umeå UniversityCompletedIdiopathic Normal Pressure Hydrocephalus
-
Uppsala University HospitalUppsala University; Swedish Society for Medical ResearchRecruitingIdiopathic Normal Pressure Hydrocephalus (INPH)Sweden
-
Johns Hopkins UniversityUniversity of Utah; Integra LifeSciences CorporationCompletedIdiopathic Normal Pressure Hydrocephalus (INPH)United States, Canada, Sweden
-
Hospital Clinic of BarcelonaHospital Universitario Reina Sofia de Cordoba; Hospitales Universitarios Virgen...UnknownCerebral Aneurysm | Intracranial Aneurysm | Aneurysm, Ruptured | Anterior Communicating Artery AneurysmSpain
-
Military University Hospital, PragueRecruitingNormal Pressure HydrocephalusCzechia
-
University Hospital, ToulouseCompleted
Clinical Trials on Endoscopic third ventriculostomy (ETV)
-
University of UtahJohns Hopkins University; University of Colorado, Denver; The Hospital for Sick... and other collaboratorsRecruitingHydrocephalusUnited States, Canada
-
Sohag UniversityNot yet recruitingHydrocephalus | Shunt Malfunction
-
University Medicine GreifswaldUnknownNormal Pressure HydrocephalusGermany
-
The Hospital for Sick ChildrenThe International Study Group for Neuroendoscopy (ISGNE); The International...CompletedHydrocephalusCanada, United Kingdom, Spain, India, United States, Poland, Hungary, Turkey, Brazil, Argentina, Germany, Israel, Italy, Netherlands, Russian Federation, Serbia
-
Johns Hopkins UniversityTerminated
-
First Affiliated Hospital Xi'an Jiaotong UniversityCompletedGastric Soft Tissue NeoplasmChina